Literature DB >> 30573791

Relapsed glioblastomas respond to regorafenib.

Peter Sidaway1.   

Abstract

Entities:  

Year:  2019        PMID: 30573791     DOI: 10.1038/s41571-018-0161-5

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  G20's Initiative for Early Childhood Development.

Authors:  Linda M Richter; Chris Desmond; Jere Behrman; Pia Britto; Bernadette Daelmans; Amanda E Devercelli; Paul Gertler; John Hoddinott; Wafaie Fawzi; Günther Fink; Joan Lombardi; Florencia Lopez Boo; Chunling Lu; Stephen Lye; Milagros Nores; Aisha Yousafzai
Journal:  Lancet       Date:  2018 Dec 22 -Jan 4 2019       Impact factor: 79.321

  1 in total
  1 in total

Review 1.  Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era.

Authors:  Augusto Leone; Antonio Colamaria; Nicola Pio Fochi; Matteo Sacco; Matteo Landriscina; Giovanni Parbonetti; Matteo de Notaris; Giulia Coppola; Elena De Santis; Guido Giordano; Francesco Carbone
Journal:  Biomedicines       Date:  2022-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.